Regadenoson and Albuterol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Regadenoson (regadenoson) and Albuterol (albuterol). Common drug interactions include nausea among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Regadenoson and Albuterol. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Regadenoson?

Regadenoson has active ingredients of regadenoson. eHealthMe is studying from 357 Regadenoson users. Check the latest studies of Regadenoson.

What is Albuterol?

Albuterol has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 161,052 Albuterol users. Check the latest studies of Albuterol.

On Jul, 20, 2026

11 people who take Regadenoson and Albuterol together, and have interactions are studied.

Regadenoson and Albuterol drug interactions.

What are the common drug interactions of Regadenoson and Albuterol, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Acute left ventricular failure (heart attack)
Acute respiratory failure
Benign intracranial hypertension (benign intracranial hypertension (bih) is a headache syndrome)
Cardiac failure
Cardiac failure congestive
Csf pressure increased
Dizziness
Hypotension (abnormally low blood pressure)
Injury

male:

Chronic kidney disease
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Mobility decreased (ability to move is reduced)
Nerve compression
Osteoporosis (bones weak and more likely to break)
Pain
Quality of life decreased
Renal failure (kidney dysfunction)
Somnolence (a state of near-sleep, a strong desire for sleep)
Deafness

What are the common drug interactions of Regadenoson and Albuterol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Benign intracranial hypertension (benign intracranial hypertension (bih) is a headache syndrome)
Csf pressure increased
Injury
Migraine (headache)
Nausea (feeling of having an urge to vomit)
Pain
Papilloedema (optic disc swelling)
Vision blurred
Visual impairment
Vomiting

40-49:

n/a

50-59:

Depression
Emotional distress
Gait disturbance
Intervertebral disc protrusion (spinal disc protrusion)
Mobility decreased (ability to move is reduced)
Nerve compression
Osteoporosis (bones weak and more likely to break)
Pain
Quality of life decreased
Acute left ventricular failure (heart attack)

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Hypotension (abnormally low blood pressure)
Nephropathy (damage to or disease of a kidney)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 36.36%
Diarrhea: 4 people, 36.36%
Infection: 3 people, 27.27%
Pain: 3 people, 27.27%
Hypersensitivity: 3 people, 27.27%
High Blood Pressure: 3 people, 27.27%
Headache (pain in head): 3 people, 27.27%
Fungal Infection: 3 people, 27.27%
Nausea (feeling of having an urge to vomit): 3 people, 27.27%
Inflammation: 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Regadenoson and Albuterol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously